Market Place
Sourcing Support
All News #Library
Biotech
Wugen Selected for FDA CMC Pilot to Support Soficabtagene Mfg
02 Apr 2026 //
PHARMIWEB
FDA Grants Wugen BTD for WU-CART-007 in R/R T-ALL/T-LBL Lymphoma
21 Jan 2026 //
BUSINESSWIRE
Wugen To Present Long-Term Follow-Up Data For CD7 CAR-T Therapy
05 Dec 2025 //
GLOBENEWSWIRE
HCW Biologics Congratulates Wugen on Successful Equity Financing
18 Sep 2025 //
GLOBENEWSWIRE
Wugen Secures $115M for Advancing WU-CART-007 CAR-T Therapy
27 Aug 2025 //
GLOBENEWSWIRE
Wugen Doses First Patients in Trial of CD7-Targeted CAR-T Therapy
20 Mar 2025 //
GLOBENEWSWIRE
Wugen Appoints Jim Faulkner as CTO
26 Feb 2025 //
GLOBENEWSWIRE
Wugen to Present Clinical Data at 2024 ASH Meeting
05 Dec 2024 //
GLOBENEWSWIRE
Wugen to Start Trial for WU-CART-007 in Leukemia & Lymphoma
12 Nov 2024 //
GLOBENEWSWIRE
Cherry T. Thomas Joins Wugen as CMO for CD7-Targeted CAR-T
12 Nov 2024 //
GLOBENEWSWIRE
Wugen`s WU-CART-007 Surpasses SOC In T-ALL LBL At EHA 2024
14 Jun 2024 //
GLOBENEWSWIRE
Wugen Gets RMAT, PRIME For WU-CART-007, Plans EHA Phase 2
20 May 2024 //
GLOBENEWSWIRE
Wugen Presents Latest Data from First-In-Human Phase 1/2 Trial of WU-CART-007
11 Dec 2023 //
GLOBENEWSWIRE
Wugen to Present New Data for WU-CART-007 and Preclinical Data for WU-NK-101
02 Nov 2023 //
GLOBENEWSWIRE
Wugen Begins First-in-Human Phase 1 Clinical Trial of WU-NK-101
15 Aug 2023 //
BUSINESSWIRE
Wugen Announces Multiple Presentations at EHA 2023 Congress
11 May 2023 //
BUSINESSWIRE
Wugen to Present Data on WU-NK-101 at AACR
29 Mar 2023 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.